R Troncone
Overview
Explore the profile of R Troncone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
118
Citations
2246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Auricchio R, Galatola M, Cielo D, Amoresano A, Caterino M, Vita E, et al.
Sci Rep
. 2019 Oct;
9(1):14303.
PMID: 31586100
Celiac disease (CeD) is a multifactorial disease influenced by both genetic and environmental risk factors. CeD genetic components are mainly due to HLA class II genes, which account for approximately...
2.
Borrelli M, Maglio M, Korponay-Szabo I, Vass V, Mearin M, Meijer C, et al.
Clin Exp Immunol
. 2017 Nov;
191(3):311-317.
PMID: 29114847
In coeliac disease (CD), anti-tissue transglutaminase 2 immunoglobulin (Ig)A antibodies (anti-TG2) are produced and deposited in the intestine. PreventCD (www.preventcd.com) is a European multi-centre study, which investigates the influence of...
3.
Elce A, Amato F, Zarrilli F, Calignano A, Troncone R, Castaldo G, et al.
Benef Microbes
. 2017 Sep;
8(5):841-847.
PMID: 28856908
Butyrate acts as energy source for intestinal epithelial cells and as key mediator of several immune processes, modulating gene expression mainly through histone deacetylation inhibition. Thanks to these effects, butyrate...
4.
Mandile R, Picascia S, Parrella C, Camarca A, Gobbetti M, Greco L, et al.
Aliment Pharmacol Ther
. 2017 Jun;
46(4):440-446.
PMID: 28627070
Background: A gluten-free diet is currently the only reliable therapeutic strategy that is approved for coeliac disease (CD). For many patients, however, compliance remains inadequate. Aim: To investigate the immunogenicity...
5.
Szajewska H, Shamir R, Chmielewska A, Piescik-Lech M, Auricchio R, Ivarsson A, et al.
Aliment Pharmacol Ther
. 2015 Mar;
41(11):1038-54.
PMID: 25819114
Background: New evidence emerged on early feeding practices and the risk of coeliac disease. Aim: To systematically update evidence on these practices to find out whether there is a need...
6.
Tosco A, Auricchio R, Aitoro R, Ponticelli D, Primario M, Miele E, et al.
Clin Exp Immunol
. 2014 Apr;
177(3):611-7.
PMID: 24773630
It has always been known that anti-tissue transglutaminase 2 (anti-TG2) antibodies are produced in the small intestine. Their serum titres correlate with mucosal damage degree and decrease on a gluten-free...
7.
Nocerino R, Granata V, di Costanzo M, Pezzella V, Leone L, Passariello A, et al.
Allergy
. 2012 Dec;
68(2):246-8.
PMID: 23205566
Atopy patch tests (APTs) have been proposed for the diagnostic approach in children with non-IgE-mediated cow's milk allergy and gastrointestinal symptoms. We aimed to investigate the benefit of APTs in...
8.
Tosco A, Aitoro R, Auricchio R, Ponticelli D, Miele E, Paparo F, et al.
Clin Exp Immunol
. 2012 Dec;
171(1):69-75.
PMID: 23199325
Anti-tissue transglutaminase 2 (anti-TG2) antibodies are present in the serum of the great majority of untreated coeliac disease (CD) patients. They are produced and deposited in the small intestinal mucosa....
9.
Canani R, Nocerino R, Terrin G, Leone L, Troncone R
Clin Exp Allergy
. 2012 Nov;
42(12):1813-4.
PMID: 23181797
No abstract available.
10.
Szajewska H, Chmielewska A, Piescik-Lech M, Ivarsson A, Kolacek S, Koletzko S, et al.
Aliment Pharmacol Ther
. 2012 Aug;
36(7):607-18.
PMID: 22905651
Background: PREVENTCD, Prevent Coeliac Disease, is an international project investigating the hypothesis of possible induction of tolerance to gluten in genetically predisposed children through introducing small quantities of gluten during...